These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6818185)

  • 1. Split course multiple daily fractionated radiotherapy schedule combined with misonidazole for the management of grade III and IV gliomas. A pilot feasibility study of the Radiotherapy Group of the EORTC.
    Ang KK; van der Schueren E; Notter G; Horiot JC; Chenal C; Fauchon F; Raps J; van Peperzeel H; Goffin JC; Vessière M; van Glabbeke M
    Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1657-64. PubMed ID: 6818185
    [No Abstract]   [Full Text] [Related]  

  • 2. Misonidazole in radiotherapy of supratentorial malignant brain gliomas in adult patients: a randomized double-blind study.
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):39-42. PubMed ID: 6343091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misonidazole combined with hyperfractionation in the management of malignant glioma.
    Fulton DS; Urtasun RC; Shin KH; Geggie PH; Thomas H; Muller PJ; Moody J; Tanasichuk H; Mielke B; Johnson E
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1709-12. PubMed ID: 6090367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misonidazole and radiotherapy to treat malignant glioma: a phase II trial of the radiation therapy oncology group.
    Carabell SC; Bruno LA; Weinstein AS; Richter MP; Chang CH; Weiler CB; Goodman RL
    Int J Radiat Oncol Biol Phys; 1981 Jan; 7(1):71-7. PubMed ID: 7263341
    [No Abstract]   [Full Text] [Related]  

  • 5. The feasibility of high-dose multiple daily fractionation and its combination with anoxic cell sensitizers in the treatment of head and neck cancer. A pilot study of the Radiotherapy Group of the EORTC (European Organisation for Research on Treatment of Cancer).
    Van den Bogaert W; van der Schueren E; Horiot JC; Chaplain G; Arcangeli G; Gonzalez D; Svoboda V
    Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1649-55. PubMed ID: 7153077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experiences with the radiosensitizer Misonidazol (author's transl)].
    Bamberg M; Tamulevicius P; Streffer C; Scherer E
    Strahlentherapie; 1981 Aug; 157(8):524-36. PubMed ID: 7268822
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report.
    Shin KH; Urtasun RC; Fulton D; Geggie PH; Tanasichuk H; Thomas H; Muller PJ; Curry B; Mielke B; Johnson E
    Cancer; 1985 Aug; 56(4):758-60. PubMed ID: 3893680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Postoperative radiotherapy of astrocytomas grade 3 and 4 with the radiosensitizer misonidazole. -End results of a multicentric controlled German study].
    Sack H; Calcanis A; Godehardt E; Weidtman V; Zülch KJ; Ammon J; Bamberg M; Herbst M; Keim H; Kleibel F; Makoski HB; Potthoff PC; Schlegel G; Schnepper E
    Strahlentherapie; 1982 Aug; 158(8):466-9. PubMed ID: 6753245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study of radiotherapy with misonidazole in head and neck cancer.
    Paterson IC; Dawes PJ; Henk JM; Moore JL
    Clin Radiol; 1981 Mar; 32(2):225-9. PubMed ID: 7214840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined modality treatment of operated astrocytomas grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy. Stage II of a prospective multicenter trial of the Scandinavian Glioblastoma Study Group.
    Hatlevoll R; Lindegaard KF; Hagen S; Kristiansen K; Nesbakken R; Torvik A; Ganz JC; Mella O; Rosengren B; Ringkjöb R
    Cancer; 1985 Jul; 56(1):41-7. PubMed ID: 2988737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late results of multiple fractions per day (MFD) with misonidazole in advanced cancer of the head and neck. A pilot study of the EORTC radiotherapy group.
    Van den Bogaert W; van der Schueren E; Van Tongelen C; Horiot JC; Chaplain G; Arcangeli G; Gonzalez D; Svoboda V
    Radiother Oncol; 1985 Feb; 3(2):139-44. PubMed ID: 3983422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma.
    Bleehen NM; Wiltshire CR; Plowman PN; Watson JV; Gleave JR; Holmes AE; Lewin WS; Treip CS; Hawkins TD
    Br J Cancer; 1981 Apr; 43(4):436-42. PubMed ID: 7016157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy of rat brain tumor using misonidazole as hypoxic cell sensitizer.
    Tamura M; Inoue H; Murata M; Koizumi H; Nakamura M; Yonome I; Niibe H
    J Cancer Res Clin Oncol; 1985; 109(3):188-92. PubMed ID: 4008513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery; preliminary results of an RTOG study.
    Nelson DF; Schoenfeld D; Weinstein AS; Nelson JS; Wasserman T; Goodman RL; Carabell S
    Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1143-51. PubMed ID: 6347995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misonidazole as a radiosensitizer in the radiotherapy of glioblastomas and oesophageal cancer. Pharmacokinetic and clinical studies.
    Tamulevicius P; Bamberg M; Scherer E; Streffer C
    Br J Radiol; 1981 Apr; 54(640):318-24. PubMed ID: 7013890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiosensitizing effect of misonidazole in radiotherapy for intracranial tumors].
    Otsuka S
    Nihon Geka Hokan; 1982 Nov; 51(6):892-906. PubMed ID: 7171270
    [No Abstract]   [Full Text] [Related]  

  • 17. Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma.
    Deutsch M; Green SB; Strike TA; Burger PC; Robertson JT; Selker RG; Shapiro WR; Mealey J; Ransohoff J; Paoletti P
    Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1389-96. PubMed ID: 2542193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperfractionated radiotherapy with or without misonidazole: results of a prospective randomized study in stage III-IV squamous cell carcinoma of the head and neck.
    Panis X; Nguyen TD; Froissart D; Demange L
    Int J Radiat Oncol Biol Phys; 1984 Oct; 10(10):1845-9. PubMed ID: 6386760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiosensitizing effect of misonidazole on intracranially transplanted tumors in mice and its clinical application (author's transl)].
    Otsuka S; Suda K; Yumitori K; Yamashita J; Oda Y; Takeuchi J; Handa H; Ono K
    Neurol Med Chir (Tokyo); 1982 May; 22(5):337-43. PubMed ID: 6180334
    [No Abstract]   [Full Text] [Related]  

  • 20. Misonidazole and irradiation in the treatment of high-grade astrocytomas: further report of the Vienna Study Group.
    Stadler B; Kärcher KH; Kogelnik HD; Szepesi T
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1713-7. PubMed ID: 6090368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.